Prospects for pluripotent stem cell therapies: Into the clinic and back to the bench

Journal of Cellular Biochemistry

Volumn 113, Issue 2, 2012, Pages 381-387

  Grabel, Laura ^a  

^a WESLEYAN UNIVERSITY   (United States)

Author keywords

Clinical trial; Embryonic stem cell; Induced pluripotent stem cell

Indexed keywords

BRAIN CORTEX; CARCINOGENESIS; CARTILAGE CELL; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL MEMBRANE POTENTIAL; CELL PROLIFERATION; CELL TYPE; CYTOLOGY; DEGENERATIVE DISEASE; DISEASE COURSE; DRUG SCREENING; EMBRYO CELL; EMBRYONIC STEM CELL; EPIGENETICS; FUNDING; GABAERGIC SYSTEM; HUMAN; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LEGAL ASPECT; NONHUMAN; PARKINSON DISEASE; PHOTORECEPTOR; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; PLURIPOTENT STEM CELL THERAPY; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SPINAL CORD INJURY; STARGARDT DISEASE; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; UNITED STATES;

ANIMALS; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; GOVERNMENT PROGRAMS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE; TERATOCARCINOMA; UNITED STATES;

ANIMALIA; IPS;

EID: 84855561934     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23364     Document Type: Review

References (51)

1. Alper J. 2009. Geron gets green light for human trial of ES cell-derived product. Nat Biotechnol 27:213-214.
2. Bartlett R. 2011. Stop using chimps as guinea pigs. New York, NY: New York Times.
3. Bibel M, Richter J, Schrenk K, Tucker KL, Staiger V, Korte M, Goetz M, Barde YA. 2004. Differentiation of mouse embryonic stem cells into a defined neuronal lineage. Nat Neurosci 7:1003-1009. (Pubitemid 39129511)
4. Bibikova M, Laurent LC, Ren B, Loring JF, Fan JB. 2008. Unraveling epigenetic regulation in embryonic stem cells. Cell Stem Cell 2:123-134. (Pubitemid 351168715)
5. Bieberich E, Silva J, Wang G, Krishnamurthy K, Condie BG. 2004. Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants. J Cell Biol 167:723-734. (Pubitemid 39565152)
6. Cai C, Grabel L. 2007. Directing the differentiation of embryonic stem cells to neural stem cells. Dev Dyn 236:3255-3266. (Pubitemid 350276384)
7. Cai C, Thorne J, Grabel L. 2008. Hedgehog serves as a mitogen and survival factor during embryonic stem cell neurogenesis. Stem Cells 26:1097-1108.
8. Chiba S, Lee YM, Zhou W, Freed CR. 2008. Noggin enhances dopamine neuron production from human embryonic stem cells and improves behavioral outcome after transplantation into Parkinsonian rats. Stem Cells 26:2810-2820.
9. Colman A, Dreesen O. 2009. Pluripotent stem cells and disease modeling. Cell Stem Cell 5:244-247.
10. Fujikawa T, Oh SH, Pi L, Hatch HM, Shupe T, Petersen BE. 2005. Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. Am J Pathol 166:1781-1791. (Pubitemid 40734401)
11. Fukuda H, Takahashi J, Watanabe K, Hayashi H, Morizane A, Koyanagi M, Sasai Y, Hashimoto N. 2006. Fluorescence-activated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation. Stem Cells 24:763-771. (Pubitemid 44464781)
12. Germain N, Banda E, Grabel L. 2010. Embryonic stem cell neurogenesis and neural specification. J Cell Biochem 111:535-542.
13. Germain N, Hartman N, Cai C, Becker S, Naegele J, Grabel L. 2011. Teratocarcinoma formation in embryonic stem cell-derived neural progenitor hippocampal transplants. Cell Transplant. In press.
14. Goldring CE, Duffy PA, Benvenisty N, Andrews PW, Ben-David U, Eakins R, French N, Hanley NA, Kelly L, Kitteringham NR, Kurth J, Ladenheim D, Laverty H, McBlane J, Narayanan G, Patel S, Reinhardt J, Rossi A, Sharpe M, Park BK. 2011. Assessing the safety of stem cell therapeutics. Cell Stem Cell 8:618-628.
15. Gong G, Ferrari D, Dealy CN, Kosher RA. 2011. Direct and progressive differentiation of human embryonic stem cells into the chondrogenic lineage. J Cell Physiol 224:664-671.
16. Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J, Canto I, Giorgetti A, Israel MA, Kiskinis E, Lee JH, Loh YH, Manos PD, Montserrat N, Panopoulos AD, Ruiz S, Wilbert ML, Yu J, Kirkness EF, Izpisua Belmonte JC, Rossi DJ, Thomson JA, Eggan K, Daley GQ, Goldstein LS, Zhang K. 2011. Somatic coding mutations in human induced pluripotent stem cells. Nature 471:63-67.
17. Gottweis H. 2010. The endless hESC controversy in the United States: History, context, and prospects. Cell Stem Cell 7:555-558.
18. Green MD, Chen A, Nostro MC, d'Souza SL, Schaniel C, Lemischka IR, Gouon-Evans V, Keller G, Snoeck HW. 2011. Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. Nat Biotechnol 29:267-272.
19. Gruen L, Grabel L. 2006. Concise review: Scientific and ethical roadblocks to human embryonic stem cell therapy. Stem Cells 24:2162-2169. (Pubitemid 44527468)
20. Gurdon JB, Melton DA. 2008. Nuclear reprogramming in cells. Science 322:1811-1815.
21. Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, Creyghton MP, Steine EJ, Cassady JP, Foreman R, Lengner CJ, Dausman JA, Jaenisch R. 2008. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133:250-264. (Pubitemid 351508307)
22. Hanna JH, Saha K, Jaenisch R. 2010. Pluripotency and cellular reprogramming: Facts, hypotheses, unresolved issues. Cell 143:508-525.
23. Harkany T, Andang M, Kingma HJ, Gorcs TJ, Holmgren CD, Zilberter Y, Ernfors P. 2004. Region-specific generation of functional neurons from naive embryonic stem cells in adult brain. J Neurochem 88:1229-1239. (Pubitemid 38280691)
24. Hartman NW, Carpentino JE, LaMonica K, Mor DE, Naegele JR, Grabel L. 2010. CXCL12-mediated guidance of migrating embryonic stem cell-derived neural progenitors transplanted into the hippocampus. PLoS ONE 5:e15856.
25. Hentze H, Graichen R, Colman A. 2007. Cell therapy and the safety of embryonic stem cell-derived grafts. Trends Biotechnol 25:24-32. (Pubitemid 44959090)
26. Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Narva E, Ng S, Sourour M, Hamalainen R, Olsson C, Lundin K, Mikkola M, Trokovic R, Peitz M, Brustle O, Bazett-Jones DP, Alitalo K, Lahesmaa R, Nagy A, Otonkoski T. 2011. Copy number variation and selection during reprogramming to pluripotency. Nature 471:58-62.
27. Ideguchi M, Palmer TD, Recht LD, Weimann JM. 2011. Murine embryonic stem cell-derived pyramidal neurons integrate into the cerebral cortex and appropriately project axons to subcortical targets. J Neurosci 30:894-904.
28. Jaenisch R, Young R. 2008. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132:567-582. (Pubitemid 351253686)
29. Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K, Steward O. 2005. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25:4694-4705. (Pubitemid 40664118)
30. Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ. 2010. Epigenetic memory in induced pluripotent stem cells. Nature 467:285-290.
31. Ko JY, Lee HS, Park CH, Koh HC, Lee YS, Lee SH. 2009. Conditions for tumor-free and dopamine neuron-enriched grafts after transplanting human ES cell-derived neural precursor cells. Mol Ther 17:1761-1770.
32. Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD. 2000. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 18:675-679. (Pubitemid 30415305)
33. Levine AD. 2011. Policy uncertainty and the conduct of stem cell research. Cell Stem Cell 8:132-135.
34. Lu B, Malcuit C, Wang S, Girman S, Francis P, Lemieux L, Lanza R, Lund R. 2009. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 27:2126-2135.
35. Moretto-Zita M, Jin H, Shen Z, Zhao T, Briggs SP, Xu Y. 2010. Phosphorylation stabilizes Nanog by promoting its interaction with Pin1. Proc Natl Acad Sci USA 107:13312-13317.
36. Murry CE, Keller G. 2008. Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development. Cell 132:661-680. (Pubitemid 351260059)
37. Nussbaum J, Minami E, Laflamme MA, Virag JA, Ware CB, Masino A, Muskheli V, Pabon L, Reinecke H, Murry CE. 2007. Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB J 21:1345-1357. (Pubitemid 46684837)
38. Pera MF. 2011. Stem cells: The dark side of induced pluripotency. Nature 471:46-47.
39. Rao MS. 2011. Funding translational work in cell-based therapy. Cell Stem Cell 9:7-10.
40. Scott CT, McCormick JB, DeRouen MC, Owen-Smith J. 2011. Democracy derived? New trajectories in pluripotent stem cell research. Cell 145:820-826.
41. Sidhu KS. 2011. New approaches for the generation of induced pluripotent stem cells. Expert Opin Biol Ther 11:569-579.
42. Zhao XY, Li W, Lv Z, Liu L, Tong M, Hai T, Hao J, Guo CL, Ma QW, Wang L, Zeng F, Zhou Q. 2009. iPS cells produce viable mice through tetraploid complementation. Nature 461:86-90.
43. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676. (Pubitemid 44233629)
44. Tang C, Lee AS, Volkmer JP, Sahoo D, Nag D, Mosley AR, Inlay MA, Ardehali R, Chavez SL, Pera RR, Behr B, Wu JC, Weissman IL, Drukker M. 2011. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol 29:829-834.
45. Taylor CJ, Bolton EM, Pocock S, Sharples LD, Pedersen RA, Bradley JA. 2005. Banking on human embryonic stem cells: Estimating the number of donor cell lines needed for HLA matching. Lancet 366:2019-2025. (Pubitemid 41773377)
46. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147. (Pubitemid 28516247)
47. Wadman M. 2011. FDA approves third human stem cell trialeditor∧ editors. Nature.com Blogs: The Great Beyond. Nature Publishing Group.
48. Wichterle H, Peljto M. 2008. Differentiation of mouse embryonic stem cells to spinal motor neurons. Curr Protoc Stem Cell biol Chapter 1:Unit 1H 1 1-1H 1:9.
49. Yamanaka S. 2010. Patient-specific pluripotent stem cells become even more accessible. Cell Stem Cell 7:1-2.
50. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
51. Zhao T, Zhang ZN, Rong Z, Xu Y. 2011. Immunogenicity of induced pluripotent stem cells. Nature 474:212-215.